Author

Tobias Kroon

Observed name: TOBIAS KROON

Institution: AstraZeneca (Sweden)

Observed institutions: Swedish University of Agricultural Sciences, AstraZeneca (Sweden), Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg

ORCID: 0000-0001-5110-4916

Observed ORCID: 0000-0001-5110-4916

OpenAlex ID: A5038104334

PPARγ and PPARα synergize to induce robust browning of white fat in vivo

2020 · Tobias Kroon, Matthew Harms, et al. · Molecular Metabolism · 89

The SGLT2 inhibitor dapagliflozin promotes systemic FFA mobilization, enhances hepatic β-oxidation, and induces ketosis

2022 · Kristina Wallenius, Tobias Kroon, et al. · Journal of Lipid Research · 74

Cellular senescence in hepatocytes contributes to metabolic disturbances in NASH

2022 · Laurianne Bonnet, Ida Alexandersson, et al. · Frontiers in Endocrinology · 44

BMP4 gene therapy enhances insulin sensitivity but not adipose tissue browning in obese mice

2019 · Jenny M. Hoffmann, John R. Grünberg, et al. · Molecular Metabolism · 26

In vivo liposomal delivery of PPARα/γ dual agonist tesaglitazar in a model of obesity enriches macrophage targeting and limits liver and kidney drug effects

2019 · Victoria Osinski, Dustin K. Bauknight, et al. · Theranostics · 26

Nicotinic acid timed to feeding reverses tissue lipid accumulation and improves glucose control in obese Zucker rats[S]

2016 · Tobias Kroon, Tania Baccega, et al. · Journal of Lipid Research · 23

Dosing profile profoundly influences nicotinic acid's ability to improve metabolic control in rats

2015 · Tobias Kroon, Ann Kjellstedt, et al. · Journal of Lipid Research · 18

Chronotherapy with a glucokinase activator profoundly improves metabolism in obese Zucker rats

2022 · Tobias Kroon, Therese Hagstedt, et al. · Science Translational Medicine · 17

Mitochondrial amidoxime‐reducing component 1 p. Ala165Thr increases protein degradation mediated by the proteasome

2024 · Tanmoy Dutta, Kavitha Sasidharan, et al. · Liver International · 16

Feedback modeling of non-esterified fatty acids in obese Zucker rats after nicotinic acid infusions

2013 · Christine Ahlström, Tobias Kroon, et al. · Journal of Pharmacokinetics and Pharmacodynamics · 14

Modeling of free fatty acid dynamics: insulin and nicotinic acid resistance under acute and chronic treatments

2017 · Robert Andersson, Tobias Kroon, et al. · Journal of Pharmacokinetics and Pharmacodynamics · 11

Optimizing nicotinic acid delivery for durable antilipolysis and improved metabolic control

2016 · Tobias Kroon · Epsilon Open Archive (Sveriges lantbruksuniversitet biblioteket (Swedish University of Agricultural Sciences)) · 3

193-OR: Chronotherapy with the Glucokinase Activator AZD1656 Greatly Affects Its Ability to Improve Metabolism in Obese Zucker Rats

2022 · TOBIAS KROON, THERESE HAGSTEDT, et al. · Diabetes · 1

1881-P: The SGLT2 Inhibitor Dapagliflozin Improves Glucose Control and Enhances Liver Fatty Acid Oxidation and Ketone Body Formation in Insulin Resistant Obese Zucker Rats

2019 · TOBIAS KROON, THERESE HAGSTEDT, et al. · Diabetes · 1

1953-P: PPARγ Agonism and FGF-21 Synergize to Robustly Induce Browning of White Fat

2019 · TOBIAS KROON, MATTHEW J. HARMS, et al. · Diabetes

Works count: 15

Citation count: 363

H-index: 11

I10-index: 11